Fidelity Investments’s Zai Lab ZLAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $23.7M | Sell |
1,262,391
-178,015
| -12% | -$3.3M | ﹤0.01% | 1716 |
|
|
2025
Q4 | $25.4M | Sell |
1,440,406
-3,261,305
| -69% | -$76.4M | ﹤0.01% | 1685 |
|
|
2025
Q3 | $159M | Sell |
4,701,711
-1,495,712
| -24% | -$51.5M | 0.01% | 948 |
|
|
2025
Q2 | $217M | Sell |
6,197,423
-180,705
| -3% | -$5.94M | 0.01% | 784 |
|
|
2025
Q1 | $231M | Buy |
6,378,128
+902,623
| +16% | +$27.8M | 0.01% | 747 |
|
|
2024
Q4 | $143M | Buy |
5,475,505
+4,830,646
| +749% | +$134M | 0.01% | 968 |
|
|
2024
Q3 | $15.6M | Sell |
644,859
-487,202
| -43% | -$9.21M | ﹤0.01% | 1792 |
|
|
2024
Q2 | $19.6M | Sell |
1,132,061
-272,356
| -19% | -$4.79M | ﹤0.01% | 1658 |
|
|
2024
Q1 | $22.5M | Buy |
1,404,417
+167,490
| +14% | +$3.53M | ﹤0.01% | 1605 |
|
|
2023
Q4 | $33.8M | Sell |
1,236,927
-31,275
| -2% | -$825K | ﹤0.01% | 1441 |
|
|
2023
Q3 | $30.8M | Sell |
1,268,202
-705,751
| -36% | -$18.8M | ﹤0.01% | 1436 |
|
|
2023
Q2 | $54.7M | Sell |
1,973,953
-1,100,116
| -36% | -$36M | ﹤0.01% | 1247 |
|
|
2023
Q1 | $102M | Sell |
3,074,069
-1,316,638
| -30% | -$50.5M | 0.01% | 979 |
|
|
2022
Q4 | $135M | Sell |
4,390,707
-316,334
| -7% | -$9.98M | 0.01% | 849 |
|
|
2022
Q3 | $161M | Buy |
4,707,041
+1,301,187
| +38% | +$55.7M | 0.02% | 756 |
|
|
2022
Q2 | $118M | Sell |
3,405,854
-1,150,975
| -25% | -$40.6M | 0.01% | 907 |
|
|
2022
Q1 | $200M | Buy |
4,556,829
+1,489,812
| +49% | +$72M | 0.02% | 778 |
|
|
2021
Q4 | $193M | Sell |
3,067,017
-711,755
| -19% | -$60.4M | 0.01% | 819 |
|
|
2021
Q3 | $398M | Sell |
3,778,772
-636,933
| -14% | -$91.4M | 0.03% | 516 |
|
|
2021
Q2 | $782M | Buy |
4,415,705
+1,037,855
| +31% | +$167M | 0.06% | 290 |
|
|
2021
Q1 | $451M | Sell |
3,377,850
-1,548,898
| -31% | -$240M | 0.04% | 459 |
|
|
2020
Q4 | $667M | Sell |
4,926,748
-1,319,690
| -21% | -$134M | 0.06% | 320 |
|
|
2020
Q3 | $520M | Sell |
6,246,438
-828,684
| -12% | -$66.5M | 0.05% | 323 |
|
|
2020
Q2 | $581M | Sell |
7,075,122
-317,525
| -4% | -$21.5M | 0.06% | 273 |
|
|
2020
Q1 | $381M | Buy |
7,392,647
+655,097
| +10% | +$34.1M | 0.05% | 319 |
|
|
2019
Q4 | $280M | Sell |
6,737,550
-1
| -0% | -$37 | 0.03% | 525 |
|
|
2019
Q3 | $218M | Hold |
6,737,551
| – | – | 0.03% | 592 |
|
|
2019
Q2 | $235M | Buy |
6,737,551
+901,962
| +15% | +$26.6M | 0.03% | 587 |
|
|
2019
Q1 | $172M | Buy |
5,835,589
+25,011
| +0.4% | +$685K | 0.02% | 703 |
|
|
2018
Q4 | $135M | Buy |
5,810,578
+7
| +0% | +$130 | 0.02% | 730 |
|
|
2018
Q3 | $113M | Buy |
5,810,571
+755,144
| +15% | +$16.4M | 0.01% | 898 |
|
|
2018
Q2 | $118M | Buy |
5,055,427
+188,745
| +4% | +$4.07M | 0.01% | 882 |
|
|
2018
Q1 | $104M | Buy |
4,866,682
+590,158
| +14% | +$13.4M | 0.01% | 971 |
|
|
2017
Q4 | $90.8M | Buy |
4,276,524
+1,508,039
| +54% | +$40.1M | 0.01% | 1040 |
|
|
2017
Q3 | $74.8M | Buy |
+2,768,485
| New | +$77.2M | 0.01% | 1110 |
|
Other funds holding ZLAB
RI
RCM
FLSM
ACM
RSCM
CWG
Fidelity Investments's ZLAB Position: Q1 2026 in Review
Fidelity Investments reduced its Zai Lab (ZLAB) stake by 12% in Q1 2026, selling an estimated $3.3M and leaving 1,262,391 shares worth $23.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1716.
Fidelity Investments first reported a position in ZLAB in Q3 2017 and has held it in 35 quarters since. The position peaked at $782M in Q2 2021. 99 funds tracked by Wall St. Rank hold ZLAB as of Q1 2026.
- Fidelity Investments held 1,262,391 shares of Zai Lab worth $23.7M as of Q1 2026.
- Fidelity Investments sold 178,015 Zai Lab shares in Q1 2026, an estimated $3.3M.
- Zai Lab made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #1716 holding.
- Fidelity Investments first reported a position in Zai Lab in Q3 2017 and has held it in 35 quarters since.
- Fidelity Investments's Zai Lab position peaked at $782M in Q2 2021.
- 99 funds tracked by Wall St. Rank held Zai Lab as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.